|
2026
|
G/S
|
Pharmaceutical preparations for use in neuroscience |
|
|
G/S
|
Pharmaceutical preparations for use in nephropathy. |
|
|
G/S
|
Pharmaceutical preparations for use in nephropathy |
|
|
G/S
|
IC 010: Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devi... |
|
|
G/S
|
pharmaceutical preparations for use in oncology |
|
2025
|
G/S
|
Downloadable computer software for health and medical data analysis and downloadable computer sof... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for early detection of cancer;... |
|
|
Invention
|
Treatment of spinal muscular atrophy.
Disclosed herein are methods for treating spinal muscular ... |
|
|
Invention
|
Machine learning enabled longitudinal analysis of positron emission tomography and computed tomog... |
|
|
Invention
|
Biomarkers and methods of treating pd-1 and pd-l1 related conditions.
Provided herein are biomar... |
|
|
Invention
|
Combination therapies for treatment of breast cancer.
Provided are combination therapies compris... |
|
|
Invention
|
Methods of treating cancers using pd-1 axis binding antagonists and taxanes.
The invention provi... |
|
|
Invention
|
Retinal image segmentation via semi-supervised learning.
Systems and methods for performing auto... |
|
|
Invention
|
Apoptosis resistant cell lines.
The present disclosure relates to eukaryotic cell lines with a s... |
|
|
Invention
|
Methods of using anti-cd79b immunoconjugates to treat follicular lymphoma.
Provided herein are m... |
|
|
Invention
|
Subcutaneous anti-her2 antibody formulations and uses thereof.
The present invention relates to ... |
|
|
Invention
|
Prevention of disulfide bond reduction during recombinant production of polypeptides. The inventi... |
|
|
Invention
|
Cell culture compositions with antioxidants and methods for polypeptide production.
Cell culture... |
|
|
Invention
|
Methods for treating pulmonary fibrotic diseases or disorders with an anti-oncostatin m receptor ... |
|
|
Invention
|
Antibody selection apparatus and methods.
Apparatus, systems, computer-readable media, articles ... |
|
|
Invention
|
Tricyclic pi3k inhibitor compounds and methods of use.
Tricyclic PI3k inhibitor compounds of For... |
|
|
Invention
|
Processes for the preparation of substituted 1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indoles.
Provide... |
|
|
Invention
|
Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodies.
The invention provides metho... |
|
|
Invention
|
Deep learning enabled prediction of drug-induced liver injury.
A method may include determining,... |
|
|
Invention
|
Methods and systems for decoding gene expression in individual cell types and disease states. Thi... |
|
|
Invention
|
Non-contrastive auxiliary loss based learning for machine learning enabled molecular analysis.
A... |
|
|
Invention
|
Dosage regimen for reducing cytokine release syndrome (crs) with anti-fcrh5/anti-cd3 bispecific a... |
|
|
Invention
|
Precision medicine for optimal dosage of combined therapies systems and methods of use thereof. T... |
|
|
Invention
|
Tmem175 modulators for the treatment of neurodegenerative disorders. The present application prov... |
|
|
Invention
|
Oxadiazole modulators of tmem175 for the treatment of neurodegenerative disorders. This applicati... |
|
|
Invention
|
Treatment of ophthalmologic diseases.
The current invention relates to antibodies, which bind to... |
|
|
Invention
|
Treatment of ophthalmologic diseases. The current invention relates to antibodies, which bind to ... |
|
|
Invention
|
Equivariant diffusion model for generative protein design.
A method may include applying a prote... |
|
|
Invention
|
Combination therapies comprising a kras g12c inhibitor and pembrolizumab.
Provided herein are me... |
|
|
Invention
|
Combinations comprising a kras g12c inhibitor, pembrolizumab and a steroid. Provided herein are m... |
|
|
Invention
|
Methods of treating cancer with anti-ccr8/anti-cd3 bispecific antibodies. The present invention r... |
|
|
Invention
|
Methods and compositions comprising a shp2 inhibitor and an egfr inhibitor. Provided herein are c... |
|
|
Invention
|
Methods of making fucosylated and afucosylated forms of a protein.
The present application relat... |
|
|
Invention
|
Zifibancimig for use in methods for treating ocular diseases. The present invention relates to to... |
|
|
Invention
|
Zifibancimig for use in methods for treating ocular diseases via an ocular implant. The present i... |
|
|
Invention
|
Plasmids for prolonged protein expression. The present disclosure relates to plasmids that may be... |
|
|
Invention
|
Methods of predicting and mitigating tryptophan oxidation. Provided herein are methods of determi... |
|
|
Invention
|
Lyophilized and frozen mrna-lnp formulations. The present invention relates to lyophilized and fr... |
|
|
G/S
|
Educational services, namely, providing presentations in the field of oncology products and disea... |
|
|
Invention
|
Methods of treating cancer using subcutaneous dosing of mosunetuzumab as a monotherapy or in comb... |
|
|
G/S
|
Pharmaceutical preparations, applied subcutaneously, for use in oncology |
|
|
Invention
|
Systems and methods for verifying large language model output using logic rules. e.g.etc.etc.). |
|
|
Invention
|
B vitamin modulation. This disclosure relates to methods of optimizing glycosylation of a recombi... |
|
|
Invention
|
Cdk2 inhibitors for the treatment of cancer. The present disclosure provides compounds of Formula... |
|
|
Invention
|
Methods and systems for prediction of peptide presentation by major histocompatibility complex mo... |
|
|
G/S
|
Pharmaceutical preparations for use in neurological disorders including Alzheimer's |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheim... |
|
|
Invention
|
Brm targeting compounds and associated methods of use.
The present disclosure relates to bifunct... |
|
|
Invention
|
Engineered adeno-associated virus capsids.
Provided herein are engineered adeno-associated virus... |
|
|
Invention
|
Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods ... |
|
|
Invention
|
Therapeutic and diagnostic methods for multiple myeloma.
The invention provides methods of dosin... |
|
|
G/S
|
Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devices |
|
|
Invention
|
Methods of treating neurodegenerative diseases.
The invention provides methods of treating tauop... |
|
|
Invention
|
Anti-mertk antibodies and their methods of use.
The present disclosure provides anti-MerTK antib... |
|
|
Invention
|
Azole modulators of cholesterol biosynthesis and their use for promoting remyelination.
The subj... |
|
|
Invention
|
Hydantoin modulators of cholesterol biosynthesis and their use for promoting remyelination.
The ... |
|
|
G/S
|
Software products for healthcare, monitoring, screening, assessment, diagnosis, and intervention,... |
|
|
Invention
|
Anti-pdl1 antibody formulations.
The invention provides stable aqueous pharmaceutical formulatio... |
|
2024
|
G/S
|
Pharmaceutical preparations for use in immunology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology, neurology and immunology |
|
|
G/S
|
Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological diseases |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer. |
|
|
G/S
|
Pharmaceutical preparations for use in ophthalmology |
|
|
G/S
|
Pharmaceutical preparations for use in ophthalmology. |
|
|
G/S
|
Electronic data collection for business purposes in the medical field Downloadable and recorded c... |
|
|
G/S
|
Education, namely providing training in the field of oncology Medical services, namely, providing... |
|
|
G/S
|
Ophthalmological apparatus and instruments for ophthalmological surgery Education, namely providi... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology and hematology |
